Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Moses

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Research|April 16, 1998
Increased incidence of matrix metalloproteinases in urine of cancer patientsM A Moses, D Wiederschain, K R Loughlin, et al.
Experimental Eye Research|May 1, 1996
Matrix metalloproteinases and their inhibitors in aqueous humorS H Huang, A P Adamis, D G Wiederschain, et al.
Brain Research|October 9, 1989
Distribution of [3H]MK801 binding in the normal aged human hippocampusM Johnson, R H Perry, F G Charlton, et al.
The American Journal of Physiology|June 1, 1997
Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic diseaseC A Peters, M R Freeman, C A Fernandez, et al.
The Journal of Urology|August 24, 1999
Fetal partial urethral obstruction causes renal fibrosis and is associated with proteolytic imbalanceR Gobet, J Bleakley, L Cisek, et al.
Basic Research in Cardiology|December 22, 2005
Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesisI Friehs, R E Margossian, A M Moran, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2000
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelJ Fang, Y Shing, D Wiederschain, et al.
The American Journal of Pathology|December 7, 2000
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cellsK R LaMontagne, M A Moses, D Wiederschain, et al.
Nano Letters|March 6, 2018
Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed NanomedicinesP Guo, B Wang, D Liu, et al.
Journal of Cellular Biochemistry|March 10, 2001
Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structuresU A Stock, D Wiederschain, S M Kilroy, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|April 16, 1998
Increased incidence of matrix metalloproteinases in urine of cancer patientsM A Moses, D Wiederschain, K R Loughlin, et al.
Experimental Eye Research|May 1, 1996
Matrix metalloproteinases and their inhibitors in aqueous humorS H Huang, A P Adamis, D G Wiederschain, et al.
Brain Research|October 9, 1989
Distribution of [3H]MK801 binding in the normal aged human hippocampusM Johnson, R H Perry, F G Charlton, et al.
The American Journal of Physiology|June 1, 1997
Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic diseaseC A Peters, M R Freeman, C A Fernandez, et al.
The Journal of Urology|August 24, 1999
Fetal partial urethral obstruction causes renal fibrosis and is associated with proteolytic imbalanceR Gobet, J Bleakley, L Cisek, et al.
Basic Research in Cardiology|December 22, 2005
Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesisI Friehs, R E Margossian, A M Moran, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2000
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor modelJ Fang, Y Shing, D Wiederschain, et al.
The American Journal of Pathology|December 7, 2000
Inhibition of MAP kinase kinase causes morphological reversion and dissociation between soft agar growth and in vivo tumorigenesis in angiosarcoma cellsK R LaMontagne, M A Moses, D Wiederschain, et al.
Nano Letters|March 6, 2018
Using Atomic Force Microscopy to Predict Tumor Specificity of ICAM1 Antibody-Directed NanomedicinesP Guo, B Wang, D Liu, et al.
Journal of Cellular Biochemistry|March 10, 2001
Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structuresU A Stock, D Wiederschain, S M Kilroy, et al.
Pageof 6